Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure

Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure

Background The angiotensin‐receptor/neprilysin inhibitor (ARNI) sacubitril/valsartan reduces hospitalization and mortality for patients with heart failure with reduced ejection fraction. However, adoption of ARNI into clinical practice has been slow. Factors influencing use of ARNI have not been ful...

Full description

Bibliographic Details
Main Authors: Nancy Luo, Steven J. Lippmann, Robert J. Mentz, Melissa A. Greiner, Bradley G. Hammill, N. Chantelle Hardy, Warren K. Laskey, Paul A. Heidenreich, Chun‐Lan Chang, Adrian F. Hernandez, Lesley H. Curtis, Pamela N. Peterson, Gregg C. Fonarow, Emily C. O'Brien
Format: Article
Language:English
Published: Wiley 2019-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
early adoption
implementation science
novel therapy
quality improvement
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.010484

Similar Items

Similar Items